We wish to inform you that the Board of Directors of Asarfi Hospital Limited ("the Company"), at its meeting held today, i.e., 07 August 2026, has considered and approved the Unaudited ....

असफ(cid:334) हॉ(cid:729)ीटल सबके िलए (cid:738)ा(cid:726) AHL/AO/2026/1339 Date: 07 August 2026 The Listing Department BSE Limited 25th Floor, Phiroze Jeejeebhoy Towers Dalal Street Mumbai – 400001 Subject: Outcome of Board Meeting held on 07 August 2026 and Submission of Unaudited Standalone and Consolidated Financial Results for the Quarter Ended 30 June 2026 pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Ref: Scrip Code: 543943 Dear Sir/Madam, Pursuant to Regulation 33 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI LODR Regulations"), we wish to inform you that the Board of Directors of Asarfi Hospital Limited ("the Company"), at its meeting held today, i.e., 07 August 2026, has considered and approved the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended 30 June 2026. Pursuant to the aforesaid Regulation, we are enclosing herewith the following: 1. Unaudited Standalone Financial Results for the quarter ended 30 June 2026. 2. Unaudited Consolidated Financial Results for the quarter ended 30 June 2026. 3. Limited Review Report on the Standalone Financial Results issued by the Statutory Auditors. 4. Limited Review Report on the Consolidated Financial Results issued by the Statutory Auditors. The Board Meeting commenced at 03:00 P.M. and concluded at 06:00 P.M Kindly take the above information on record. Thanking you. Yours faithfully, For Asarfi Hospital Limited UDAI PRATAP SINGH Managing Director DIN: 08453794 Asarfi Hospital Limited Baramuri, P.O.: B Polytechnic, Dhanbad 828 130 || CIN: L85110JH2005PLC011673 Branch Office: Khatal Road, Dhaiya, ISM, Dhanbad 826004 || www.asarfihospital.com Phone: 7808368888, 9234302735 || Email: info@asarfihospital.com M/S R. K. THAKKAR & CO. Chartered Accountants Below ‘Central Bank of India’, Bank More, Dhanbad, 826001 Mobile: 6203797936; email: rkthakkarco@gmail.com Independent Auditor's Limited Review Report on the Quarterly and Year to Date Unaudited Standalone Financial Results of the Company Pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended Review Report to, The Board of Directors, Asarfi Hospital Limited Baramuri, Bishunpur Polytechnic, Dhanbad- 828130 Jharkhand Dear Sir, Re: Limited Review Report of the Unaudited Standalone Financial Results for the period from 1st April 2026 to 30th June 2026. We have reviewed the accompanying statement of unaudited standalone financial results of ASARFI HOSPITAL LIMITED, year to date from 1st April 2026 to 30th June 2026 ("the Statement") attached herewith, being submitted by the Company pursuant to the requirement of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, ('the Regulation') as amended (the "Listing Regulations"). This Statement which is the responsibility of the Company's Management and approved by the Board of Directors has been prepared in accordance with the recognition and measurement principles laid down in the Accounting Standard 25 "Interim Financial Reporting" ("AS 25"), prescribed under Section 133 of the Companies Act, 2013 read with relevant rules issued there under and other accounting principles generally accepted in India. Our responsibility is to issue a report on the Statement based on our review. We conducted our review in accordance with Standard on Review Engagements (SRE) 2410, “Review of Interim Financial Information Performed by the Independent Auditor of the Entity”. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. Based on our review conducted as above, nothing has come to our attention that cause us to believe that the accompanying statement of Unaudited Financial Results prepared in accordance with applicable Accounting Standards specified under Section 133 of the Companies Act, 2013 as amended, read with relevant rules issued thereunder and other recognized accounting practices and policies has not disclosed the information required to be disclosed in terms of the Regulation 33 of SEBI ( Listing Obligations and Disclosure Requirement) , read with the Circular, including the matter in which it is to be disclosed, or that it contains any material misstatement. For R K Thakkar & Co Chartered Accountants FRN: 002690C Place: Dhanbad Himanshu Kumar Dokania Date: 07.08.2026 (Partner) UDIN: 26415931FQZXXE3966 Membership No. 415931 Asarfi Hospital Limited (CIN: L85110JH2005PLC011673) (Address: Baramuri, Bishunpur Polytechnic, Dhanbad) Standalone Unaudited Balance Sheet as at 30 June 2026 (` in Lakhs) As at Particulars 30-Jun-26 31-Mar-26 Unaudited Audited I. EQUITY AND LIABILITIES (1) Shareholders’ funds (a) Share Capital 1 ,967.73 1 ,967.73 (b) Reserves and Surplus 8 ,310.50 7 ,883.66 Total 1 0,278.23 9,851.39 (2) Non-current liabilities (a) Long-term Borrowings 3 ,492.01 3 ,500.88 (b) Deferred Tax Liabilities (net) 290.10 302.33 (c) Other Long-term Liabilities 720.11 724.35 (d) Long-term Provisions 189.75 109.34 Total 4 ,691.97 4,636.90 (3) Current liabilities (a) Short-term Borrowings 1 ,987.62 2 ,254.85 (b) Trade Payables - Due to Micro and Small Enterprises 1 ,752.43 1 ,463.32 - Due to Others 199.18 193.04 (c) Other Current Liabilities 1 ,060.94 928.17 (d) Short-term Provisions 147.74 6 1.60 Total 5 ,147.91 4,900.98 Total Equity and Liabilities 2 0,118.11 19,389.27 II. ASSETS (1) Non-current assets (a) Property, Plant and Equipment and Intangible Assets (i) Property, Plant and Equipment 1 0,545.33 1 0,814.13 (ii) Capital Work-in-progress 396.70 175.91 (b) Non-current Investments 1 .00 1 .00 (c) Long term Loans and Advances 359.36 280.45 (d) Other Non-current Assets 1 ,143.30 1 ,011.99 Total 1 2,445.69 12,283.48 (2) Current assets (a) Inventories 310.68 321.87 (b) Trade Receivables 6 ,464.56 5 ,406.67 (c) Cash and cash equivalents 804.39 1 ,293.71 (d) Short-term Loans and Advances 7 3.08 5 3.84 (e) Other Current Assets 1 9.71 2 9.70 Total 7 ,672.42 7,105.79 Total Assets 2 0,118.11 19,389.27 For and on behalf of the Board of Place: Dhanbad Asarfi Hospital Limited Date: 07.08.2026 Udai Pratap Singh Madhuri Singh Harendra Singh CS Sudipa Singh Managing Director Director CFO Company Secretary 08453794 6562038 BANPS9243R ACS No. 56989 Asarfi Hospital Limited (CIN: L85110JH2005PLC011673) (Address: Baramuri, Bishunpur Polytechnic, Dhanbad) Statement of Standalone Unaudited Financial Results for the quarter ended 30 June 2026 (` in Lakhs) Quarter ended Year Ended Particulars 30-Jun-26 31-Mar-26 30-Jun-25 31-Mar-26 Unaudited Refer Notes 7 Unaudited Audited Revenue from Operations 4,734.47 4,503.47 3,566.41 1 7,319.69 Other Income 59.26 66.54 141.63 278.46 Total Income 4,793.73 4,570.01 3,708.04 1 7,598.15 Expenses Cost of Material Consumed 748.21 688.31 590.56 2,675.11 Purchases of Stock in Trade 317.66 332.26 304.64 1,290.69 Change in Inventories of work in progress and finished goods 18.14 (33.42) (37.82) (85.25) Employee Benefit Expenses 786.22 685.76 578.16 2,621.48 Finance Costs 116.92 70.51 121.88 424.37 Depreciation and Amortization Expenses 313.36 274.27 295.95 1,144.19 Other Expenses 1,922.48 2,044.90 1,427.53 7,266.61 Total expenses 4,222.99 4,062.59 3,280.90 1 5,337.20 Profit/(Loss) before Exceptional and Extraordinary Item and Tax 570.74 507.41 427.14 2,260.95 Exceptional Item - - - - Profit/(Loss) before Extraordinary Item and Tax 570.74 507.41 427.14 2,260.95 Extraordinary Item - - - Profit/(Loss) before [Showing first 8,000 characters — download PDF for full document]